Super bullish investor Zhang Jianping holds over 5 billion in unrealized gains from his shares in Cambrian Genomics.

On the evening of August 26th, Cambrian released its semi-annual report for 2025, which is the best "report card" the company has produced since its listing, completing a magnificent turnaround from huge losses to huge profits. Data shows that the super bull investor Zhang Jianping bought Cambrian at the end of 2024 and became one of the top ten shareholders, holding 5.3388 million shares; in the first quarter of this year, he further increased his position by 747,500 shares. Based on the stock price on August 26th, Zhang Jianping's shareholding value has reached 8.089 billion yuan. If calculated based on the average purchase price in the fourth quarter of last year and the first quarter of this year, Zhang Jianping's purchase cost is approximately 3.046 billion yuan. If Zhang Jianping has not sold Cambrian since establishing his position, his unrealized gains would currently be as high as 5.043 billion yuan.